Thermo Fisher Scientific Showcases New Integrated LC-MS Drug Discovery Workflow
for Maximizing Sample Throughput


San Jose, CA (March 20, 2008) Thermo Fisher Scientific Inc., the world leader in serving science, announces the integration of Thermo Scientific Aria LX multiplexing technology with QuickQuan software. The combination enables users to increase the throughput of compounds processed in high-throughput liquid chromatography-mass spectrometry (LC-MS) assays by a factor of four. This instrument accelerates the pace of drug discovery for pharmaceutical companies, streamlining the workflow by maximizing the productivity of a single MS detector.

The unique Thermo Scientific multiplexing technology is the only truly independent, parallel, multichannel system in the industry, bringing the productivity of up to four separate LC systems to a single MS. The Thermo Scientific TSQ Quantum triple quadrupole mass spectrometer and an Aria LX-4 System can process as many samples as four standalone LC-MS/MS systems. The multiplexed system ensures maximum performance of the MS so the user can boost productivity without compromising data quality or sensitivity.

For laboratories that perform high-throughput screening, this integrated solution allows scientists to quickly assess thousands of new chemical entity samples in drug discovery research. QuickQuan software performs automated optimization of MS/MS parameters, enabling the rapid analysis of compounds. Data generated from QuickQuan can be seamlessly transferred to the Thermo Scientific Galileo LIMS or QuickCalc software powered by Gubbs Inc. GMSU.

The integration of these innovative Thermo Scientific products into a single solution demonstrates Thermo Fishers commitment to developing technologies for our customers that simplify their processes and improve laboratory productivity, said Dr. Ian Jardine, vice president of global research and development for Thermo Fisher Scientific. As the leader in mass spectrometry, we have an unmatched portfolio that enables us to develop sophisticated, yet intuitive, workflows for our customers.

For more information on the new Thermo Scientific integrated LC-MS drug discovery workflow, please email analyze@thermofisher.com, call +1 800-532-4752 or visit www.thermo.com/ms.


Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With annual revenues of $10 billion, we have more than 30,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit www.thermofisher.com.

For further press information please contact: Laura Browne, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire. CW4 8AA United Kingdom Tel: +44 1477 539539 Fax: +44 1606 1477 539540 Email: thermo@scottpr.com